Albemarle Co. (NYSE:ALB) has earned a consensus rating of “Buy” from the twenty-three research firms that are presently covering the firm, Marketbeat reports. Ten research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $129.53.

Several equities analysts have recently commented on ALB shares. Oppenheimer upped their price target on shares of Albemarle from $133.00 to $157.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Deutsche Bank lowered shares of Albemarle from a “buy” rating to a “hold” rating in a research note on Tuesday, November 14th. BMO Capital Markets assumed coverage on shares of Albemarle in a research note on Tuesday, October 24th. They set an “outperform” rating and a $160.00 price objective for the company. Nomura upped their price objective on shares of Albemarle to $159.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Finally, Zacks Investment Research raised shares of Albemarle from a “hold” rating to a “buy” rating and set a $157.00 price target for the company in a research report on Tuesday, October 17th.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALB. Northwestern Mutual Wealth Management Co. lifted its holdings in Albemarle by 2.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 20 shares during the period. Thompson Davis & CO. Inc. raised its stake in shares of Albemarle by 650.0% in the third quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock valued at $102,000 after buying an additional 650 shares during the period. Smithfield Trust Co. raised its stake in shares of Albemarle by 16.1% in the second quarter. Smithfield Trust Co. now owns 1,008 shares of the specialty chemicals company’s stock valued at $106,000 after buying an additional 140 shares during the period. Highlander Capital Management LLC bought a new stake in shares of Albemarle in the second quarter valued at $106,000. Finally, Advisory Services Network LLC raised its stake in shares of Albemarle by 43.7% in the second quarter. Advisory Services Network LLC now owns 1,273 shares of the specialty chemicals company’s stock valued at $134,000 after buying an additional 387 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.

Albemarle (NYSE ALB) traded down $0.51 during trading on Thursday, reaching $127.48. 1,675,300 shares of the company were exchanged, compared to its average volume of 1,179,627. Albemarle has a 52-week low of $85.60 and a 52-week high of $144.99. The stock has a market capitalization of $14,142.33, a P/E ratio of 31.68, a price-to-earnings-growth ratio of 1.94 and a beta of 1.69. The company has a current ratio of 2.11, a quick ratio of 1.56 and a debt-to-equity ratio of 0.35.

Albemarle (NYSE:ALB) last posted its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.01. The business had revenue of $755.00 million for the quarter, compared to analysts’ expectations of $732.19 million. Albemarle had a net margin of 30.07% and a return on equity of 11.61%. The business’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.91 earnings per share. analysts anticipate that Albemarle will post 4.46 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Friday, December 15th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $1.28 annualized dividend and a yield of 1.00%. Albemarle’s dividend payout ratio is currently 16.56%.

COPYRIGHT VIOLATION WARNING: This report was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://theolympiareport.com/2017/12/07/albemarle-co-alb-receives-consensus-rating-of-buy-from-brokerages.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.